BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 31, 2011
View Archived Issues
Rapid eQuIC assay detects abnormal form of prion protein in tissues and bodily fluids
Read More
Novel arylindenopyrimidine compound disclosed
Read More
Pfizer files application in Japan seeking additional uses of Diflucan
Read More
Unigene Laboratories and Cara Therapeutics form agreement for phase I CR-845 trial
Read More
Phosphagenics and 3M complete initial formulation of improved oxycodone transdermal patch
Read More
Clinical phase III and preclinical data disclosed on antidepressant Lu-AA-21004
Read More
Interim phase II/III analysis points to benefits of Urocidin in non-muscle-invasive bladder cancer
Read More
Preclinical data support development of MPI-0485520 for rheumatoid arthritis
Read More
Otsuka Pharmaceutical presents new vasopressin receptor antagonists
Read More
Rivaroxaban is a viable option for secondary stroke prevention in patients with atrial fibrillation
Read More
Filgrastim is safe and may reduce lesion size after recent stroke
Read More
Pro-Pharmaceuticals changes name to Galectin Therapeutics
Read More
Leo Pharma begins phase II trial of LEO-90100 cutaneous spray ointment for psoriasis
Read More
XenoPort begins phase III arbaclofen placarbil trial in multiple sclerosis
Read More
MediGene and Johns Hopkins to collaborate on development of vaccine candidates from AAVLP program
Read More
ReNeuron completes dosing in first cohort of PISCES trial
Read More
BioCis Pharma and Lx Therapies combine to form Laurantis Pharma
Read More
TetraLogic closes funding round to advance TL-32711
Read More
ProteaBio Europe and Mayoly-Spindler's phase I/IIA MS-1819 trial meets expectations
Read More
Nuvilex completes acquisition of pancreatic cancer treatment technology
Read More
Pharmascience to expand research and development activities with acquisition of Aegera Therapeutics
Read More
OncoSec Medical to begin three phase II trials of ElectroImmunotherapy technology in cancer
Read More
Cosmo Pharmaceuticals files MAA in E.U. for Budesonide MMX in active ulcerative colitis
Read More
Ono Pharmaceutical to pay PAION second milestone payment with start of phase II remimazolam trial
Read More
AstraZeneca and Heptares join to discover and develop GPCR-targeting medicines
Read More
